SynthesisBMC nephrology2026

Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials.

Zhonghua Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.